Vaccines are the biological products which improves immunity against specific disorder or disease. Vaccines are manufactured from living attenuated organisms, or killed disease-causing microorganism. Vaccination plays an important role to maintain sustainable health of people across various countries. Increase in demand vaccination to treat various diseases is expected to fuel the growth of human vaccines market, in this forecast period.
Increase in prevalence of infectious diseases will increase the demand for vaccines. It is expected to boost the human vaccines market growth. Furthermore, technological advancements in vaccine delivery devices and rise in immunization programs supplement market is expected to propel the growth of global human vaccines market growth. In other hand, rise in government initiatives to create awareness regarding vaccination have the positive impact on global human vaccines market growth.
However, storage condition of vaccine is the major restraining factor which expected to hinder the growth of global human vaccines market growth. Also, longer timelines required to vaccine production, and high monetary inputs associated with vaccines will affect the global human vaccines market growth.
Global Human Vaccines Market is segmented into technology Conjugate Vaccine, Inactivated & Subunit Vaccines, Live Attenuated Vaccine, Recombinant Vaccine, and Toxoid Vaccine, by Patient Type Pediatric Patients, and Adult Patient, by infection type Pneumococcal Infection, DTP, Influenza, Polio, Rotavirus, and Others. Further, Global Human Vaccines Market is segmented into Route of Administration such as Intramuscular & Subcutaneous, Oral, and Others.
Also, Global Human Vaccines Market is segmented into five regions such as North SAmerica, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Various key players are discussed in this report such as GlaxoSmithKline PLC, Pfizer Inc., Merck & Co. Inc., Sanofi Pasteur SA,Johnson& Johnson, AstraZeneca, Serum Institute of India Pvt. Ltd., , Daiichi Sankyo Company Limited, Bavarian Nordic, Biological , CSL Limited, and Bharat Biotech.
Global Human Vaccines Market Drivers
Increase in prevalence of infectious diseases will increase the demand for vaccines. It is expected to boost the human vaccines market growth. Furthermore, technological advancements in vaccine delivery devices and rise in immunization programs supplement market is expected to propel the growth of global human vaccines market growth. In other hand, rise in government initiatives to create awareness regarding vaccination have the positive impact on global human vaccines market growth.
Global Human Vaccines Market Restraints
However, storage condition of vaccine is the major restraining factor which expected to hinder the growth of global human vaccines market growth. Also, longer timelines required to vaccine production, and high monetary inputs associated with vaccines will affect the global human vaccines market growth.
Global Human Vaccines Market Segmentation
Global Human Vaccines Market is segmented into technology Conjugate Vaccine, Inactivated & Subunit Vaccines, Live Attenuated Vaccine, Recombinant Vaccine, and Toxoid Vaccine, by Patient Type Pediatric Patients, and Adult Patient, by infection type Pneumococcal Infection, DTP, Influenza, Polio, Rotavirus, and Others. Further, Global Human Vaccines Market is segmented into Route of Administration such as Intramuscular & Subcutaneous, Oral, and Others.
Also, Global Human Vaccines Market is segmented into five regions such as North SAmerica, Latin America, Europe, Asia Pacific, and Middle East & Africa.
Global Human Vaccines Market Key Players
Various key players are discussed in this report such as GlaxoSmithKline PLC, Pfizer Inc., Merck & Co. Inc., Sanofi Pasteur SA,Johnson& Johnson, AstraZeneca, Serum Institute of India Pvt. Ltd., , Daiichi Sankyo Company Limited, Bavarian Nordic, Biological , CSL Limited, and Bharat Biotech.
Global Human Vaccines Market Taxonomy
By Technology
- Conjugate Vaccine
- Inactivated & Subunit Vaccines
- Live Attenuated Vaccine
- Recombinant Vaccine
- Toxoid Vaccine
By Patient Type
- Pediatric Patients
- Adult Patient
By Infection Type
- Pneumococcal Infection
- DTP
- Influenza
- Polio
- Rotavirus
- Others
By Route of Administration
- Intramuscular & Subcutaneous
- Oral
- Others
By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Frequently Asked Questions about the Human Vaccines Market
What is the estimated value of the Human Vaccines Market?
What is the growth rate of the Human Vaccines Market?
What is the forecasted size of the Human Vaccines Market?
Who are the key companies in the Human Vaccines Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 155 |
| Published | February 2022 |
| Forecast Period | 2020 - 2027 |
| Estimated Market Value ( USD | $ 61040 Million |
| Forecasted Market Value ( USD | $ 125490 Million |
| Compound Annual Growth Rate | 10.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
Table of Contents
1. Executive Summary
3. Market Background
5. Global Human Vaccines Market Analysis, By Technology
6. Global Human Vaccines Market Analysis, By Patient Type
7. Global Human Vaccines Market Analysis, By Infection Type
8. Global Human Vaccines Market Analysis, By Route of Administration
9. Global Human Vaccines Market Analysis, By Region
10. North America Human Vaccines Market Analysis and Forecast (2017-2027)
11. Europe Human Vaccines Market Analysis and Forecast (2017-2027)
12. Asia Pacific Human Vaccines Market Analysis and Forecast (2017-2027)
13. Latin America Human Vaccines Market Analysis and Forecast (2017-2027)
14. Middle East & Africa Human Vaccines Market Analysis and Forecast (2017-2027)
15. Competition Analysis
16. Company Profiles
Companies Mentioned
- GlaxoSmithKline PLC
- Pfizer Inc.
- Merck & Co. Inc.
- Sanofi Pasteur SA
- Johnson& Johnson
- AstraZeneca
- Serum Institute of India Pvt. Ltd.
- Daiichi Sankyo Company Limited
- Bavarian Nordic
- Biological
- CSL Limited
- Bharat Biotech
